Sana Biotechnology, Inc. (NASDAQ:SANA) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 8:00 AM EDT
Company Participants
Steven Harr – President, CEO & Director
Conference Call Participants
Yanan Zhu – Wells Fargo Securities, LLC, Research Division
Presentation
Yanan Zhu
Senior Equity Analyst
Great. Thanks, everyone, for being here. My name is Yanan Zhu. I’m one of the biotech analysts here at Wells Fargo. It is my great pleasure to be doing this fireside chat with Steve Harr, CEO of Sana Biotechnology. Steve, thank you so much for being here.
Steven Harr
President, CEO & Director
Thank you for having me, and I really appreciate Wells Fargo putting this together. And I’m sure you know we’ll be making forward-looking statements during this time, and people may want to take a look at our disclosures and risk factors in the 10-Q. We spend a lot of time writing them. They’re usually worth reading.
Question-and-Answer Session
Yanan Zhu
Wells Fargo Securities, LLC, Research Division
Great. Great. Steve, perhaps you could start us off by providing an overview of the company and also review the catalysts investors should pay attention to in the next 6 to 12 months.
Steven Harr
President, CEO & Director
Sure. I like the former question. I’ll let you guys figure out what the stock catalysts are. I’m pretty thoughtful on how we’re building the business and maybe how we think about progress that we’re making and then you guys can figure out what will happen to the stock price. A couple of things that I’ll just take a step back. We were founded with the idea that cell and gene therapy would be one of the more important transformations in medicine over the coming decades. And there’s nothing that we’ve seen over the last few years, even though it’s been a super challenging field
#Sana #Biotechnology #SANA #Presents #Wells #Fargo #20th #Annual #Healthcare #Conference